Cu2MoS4 nanozymes reduced bacterial defenses through a dual mechanism to amplify cuproptosis-like death and accelerate the healing of burn-infected wounds Authors: Yunfeng Zheng, Shuo Zhang, Xu-Lin Chen, Xianwen Wang Published: 2026 ABSTRACT AbstractBurn injuries disrupt the skin barrier function, significantly predisposing patients to bacterial invasion. With the widespread use of antibiotics, bacteria have evolved various resistance mechanisms, significantly weakening the efficacy of traditional antibiotics. The application of copper-based nanozymes is still limited by issues such as concentration dependence and bacterial defense. Here, hollow-structured copper-molybdenum bimetallic Cu2MoS4 nanozymes were successfully synthesized using a simple hydrothermal method. In vitro antibacterial experiments showed that Cu2MoS4 nanozymes have multiple types of enzyme activities producing a robust burst of ROS that directly kill bacteria. Transcriptomic analysis demonstrated that the expression of the lpdG gene was downregulated by Cu2MoS4 nanozymes, resulting in aberrant intracellular copper retention and thereby inducing a cuproptosis-like death. Moreover, the transcription of genes pertinent to the arginine deiminase (ADI) pathway was downregulated by Cu2MoS4 nanozymes, resulting in impaired ATP production in deep-layer biofilm bacteria and disruption of their metabolic processes, thereby contributing to a reduction in bacterial defense. Concurrently, the expression of sodB and ahpC was directly inhibited by the molybdenum component, which attenuated the bacterial antioxidant defense system and consequently increased susceptibility to ROS-mediated damage. The downregulation of bacterial defenses induces further intracellular copper ion accumulation, synergistically amplifying the cuproptosis-like death and enhancing bactericidal capability. In animal experiments, tissue inflammation was reduced and angiogenesis as well as granulation tissue regeneration were promoted, which effectively accelerated wound healing. The bimetallic copper/molybdenum nanozyme-based multi-mechanistic synergistic antibacterial strategy proposed herein provides a novel clinical strategy for the targeted therapy of antibiotic-resistant bacterial infections following burns.Keywords: Bacterial defense, Molybdenum, Cuproptosis-like death, ADI pathway, Burn wounds infection Introduction Burns are severe injuries caused by various harmful factors such as high-temperature heat sources and often pose a threat to the patient's life [1]. Burn patients, due to the lack of a skin barrier and the exposure of soft tissues to pathogens, are often at risk of severe wound infections and even shock [2,3]. Currently, in clinical practice, antibiotics remain the primary treatment for burn wound infections. They can effectively control the occurrence and progression of systemic infections, significantly improving patient survival rates [4,5]. However, with the widespread use of antibiotics, bacteria are forced to continuously evolve resistance mechanisms to defend against the attack of antibiotics [6]. Complications arising from antibiotic defense are extremely serious, not only prolonging hospital stays but also doubling the overall cost of patient care, imposing a heavy financial burden on patients. Pseudomonas aeruginosa (P. aeruginosa), as a common drug-resistant bacterium in clinical settings, has broad susceptibility and can cause various types of infections [7]. P. aeruginosa commonly colonizing healthcare environments, is highly likely to cause infections in burn wounds, endangering human life and health [8]. P. aeruginosa initially colonizes burn wounds and then forms a dense biofilm, enabling it to persist on surfaces for extended periods. This allows it to evade immune responses and resist antimicrobial treatments, making the management of associated infections extremely challenging [9]. In general, P. aeruginosa tends to utilize aerobic respiration to achieve the highest energy yield [10]. However, hypoxic conditions are often present in the deeper layers of P. aeruginosa biofilms. P. aeruginosa activates the arginine deiminase (ADI) metabolic pathway, which is widely distributed among bacteria. Utilization of L-arginine in anaerobic settings allows P. aeruginosa to generate a substantial amount of ATP in the absence of oxygen, maintaining normal bacterial metabolism, thereby significantly enhancing bacterial defense [[11], [12], [13]]. P. aeruginosa not only continuously produces large amounts of ATP through dual metabolic mechanisms to maintain its normal life activities in harsh environments, but has also evolved a powerful antioxidant defense system to help it resist attacks from exogenous reactive oxygen species (ROS) [[14], [15], [16]]. However, as the concentration of ROS increases, P. aeruginosa has evolved an antioxidant stress system with SOD as a key enzyme, which can rapidly decompose toxic ROS into oxygen and H2O2, followed by ahpC breaking down the H2O2 into non-toxic oxygen and water [17,18]. This oxidative stress defense system also significantly enhances bacterial defense to antibiotics [19]. Currently, the development of new antibiotics lags far behind the progression of bacterial defense, making the exploration of more effective alternative therapies particularly crucial for controlling P. aeruginosa infections. Nanozymes are nanomaterials that have natural enzyme activity [20,21]. They are easy to prepare and stable in performance, and have gained broad utilization in the field of antibacterial therapy [22]. Copper-based nanozymes possess high oxidase-like (OXD-like) and peroxidase-like (POD-like) enzyme activities, enabling them to generate ROS via Fenton-like reactions to effectively kill bacteria [[23], [24], [25]]. In addition, copper-based nanozymes can cause abnormal abnormal copper ion accumulation in bacterial, which can further be reduced to Cu+ inside the bacterial cells, leading to proteins oligomerization associated with the tricarboxylic acid cycle (TCA cycle), thus impairing bacterial energy metabolism and causing oxidative damage [[26], [27], [28], [29], [30]]. This bactericidal mechanism is similar to copper-induced cell death in eukaryotic cells, which can effectively kill bacteria and is referred to as cuproptosis-like death [[31], [32], [33]]. Although copper-based nanozymes exhibit good antibacterial properties, their copper-dependent cytotoxicity shows a significant concentration dependence [34]. In recent years, molybdenum-based nanozymes have shown outstanding potential in photothermal therapy due to their excellent peroxidase-like activity and unique electronic structure [35,36]. Related studies have confirmed that their antibacterial mechanism not only involves oxidative stress but also reduces bacterial defenses [37]. Copper-based nanozymes and molybdenum components demonstrate their unique functions, exploring the specific synergistic antibacterial mechanism of the copper/molybdenum bimetallic nanozymes may provide new ideas toward the development of innovative antimicrobial agents. In this study, hollow-structured copper-molybdenum bimetallic Cu2MoS4 nanozymes were successfully synthesized using a simple hydrothermal method. In in vitro antibacterial experiments, Cu2MoS4 nanozymes have multiple types of enzyme activities producing a robust burst of ROS to directly kill bacteria. Cu2MoS4 nanozymes can deplete the endogenous GSH in bacteria, reducing the clearance of ROS within bacterial cells. Sequencing results showed that Cu2MoS4 nanozymes downregulated the lpdG gene, causing an abnormal accumulation of copper ions inside bacteria, thereby disrupting the TCA cycle and the oxidative respiratory chain, disrupting ATP production and causing massive lipid peroxide accumulation, inducing the bactericidal cuproptosis-like death. Moreover, Cu2MoS4 nanozymes disrupted ATP production in the deep layers of biofilm-associated bacteria by downregulating genes related to the ADI pathway, interfering with normal metabolism and persistent bacterial formation, which helps reduce bacterial defense. Additionally, molybdenum directly downregulated the expression of bacterial sodB and ahpC, impairing their antioxidant defense mechanisms and further reducing bacterial resistance. The downregulation of bacterial defenses induces further intracellular copper ion accumulation, synergistically amplifying the cuproptosis-like death and enhancing bactericidal capability (Scheme 1). In animal experiments, Cu2MoS4 nanozymes effectively promoted wound healing by attenuating tissue inflammation, enhancing angiogenesis, and facilitating granulation tissue regeneration. Therefore, this copper/molybdenum based multi-mechanism antibacterial strategy presents a new solution for managing drug-resistant bacteria after burn injury. (A) Preparation process of Cu2MoS4 nanozymes. (B) Mechanism by which Cu2MoS4 nanozymes weakens bacterial defenses, causing oxidative stress and cuproptosis-like death. (C) Cu2MoS4 nanozymes external antibacterial mechanism. (D) Cu2MoS4 nanozymes promote the healing of burn-infected wounds. Results and discussion Preparation and characterization of Cu2MoS4 nanozymes Using Cu2O as the initial sacrificial template and adding glucose for structural protection, Cu2MoS4 nanozymes were synthesized through a simple hydrothermal approach (Fig. 1A). TEM revealed that the Cu2MoS4 nanozymes exhibited a hollow spherical morphology. Energy dispersive spectroscopy (EDS) was used to analyze its elemental composition, indicating that copper (blue), molybdenum (red), and sulfur (green) were uniformly arrayed on the surface of Cu2MoS4 nanozymes, successfully forming hollow spherical Cu2MoS4 nanozymes (Fig. 1B–D). Cu2MoS4 nanozymes were observed via high-resolution TEM (HRTEM). The measured lattice spacing of 0.30 nm matches well with the plane of (112) (Fig. 1E). X-ray diffraction (XRD) analysis of Cu2MoS4 nanozymes displayed diffraction peaks corresponding to the (002), (101), (112), (013), (202), (220), and (204) crystal planes of Cu2MoS4 nanozymes (Fig. S1). To further characterize the elemental composition and chemical states of each element in Cu2MoS4 nanozymes, XPS was conducted, revealing that copper mainly existed in the forms of Cu+ (933.5 eV, 950.5 eV) and Cu2+ (934.8 eV, 954.2 eV), while molybdenum was present in the valence states of Mo4+ (229.2 eV) and Mo6+ (230.5 eV) (Fig. 1F–H). This redox-coupled system of Cu+/Cu2+ and Mo4+/Mo6+ lays the foundation for the excellent enzymatic activity of Cu2MoS4 nanozymes [38]. Synthesis, characterization, and multi-enzyme activities of Cu2MoS4 nanozymes. (A) Mechanistic diagram of synthesis. (B) TEM images of the Cu2MoS4 nanozymes. (C–D) HAADF images and elemental mapping images of the Cu2MoS4 nanozymes. (E) HRTEM image of the Cu2MoS4 nanozymes. (F–H) XPS spectra of the Cu2MoS4 nanozymes. (I) Cu2MoS4 nanozymes consumption of GSH concentration curve, using DTNB probe. (J) UV–vis spectra of the TMB in different groups (H2O2, TMB, TMB + H2O2, Cu2MoS4+ TMB, Cu2MoS4+ H2O2, and Cu2MoS4+ H2O2+ TMB). (K) UV–vis spectra of TMB with varying Cu2MoS4 nanozymes concentrations. (L) UV-vis spectra of TMB with varying H2O2 concentrations. (M) UV-vis spectra of OPD across different experimental groups. (N) UV–vis spectra of OPD with varying Cu2MoS4 nanozymes concentrations. (O) UV–vis spectra of OPD in different concentrations of H2O2. Evaluation of the multienzyme activities of Cu2MoS4 nanozymes To evaluate the multienzyme activities of Cu2MoS4 nanozymes, OPD and TMB were first used as colorimetric substrates to detect their POD-like and OXD-like activities, respectively. OPD and TMB are two classic chromogenic substrates: they can be oxidized to OX-OPD and OX-TMB, exhibiting characteristic absorption peaks at 435 nm and 652 nm, respectively, with a visible color change from colorless to colored. Based on this, the catalytic performance of Cu2MoS4 nanozymes on the two substrates in the presence of H2O2 was tested: TMB was rapidly oxidized to a blue product, while OPD was oxidized to a yellow product, thereby confirming its peroxidase-like activity (Fig. 1J–M). Furthermore, the colorimetric reaction of Cu2MoS4 nanozymes was investigated under H2O2-free conditions. The results revealed that as the concentration of Cu2MoS4 increases, the peaks of TMB and OPD gradually increase (Fig. 1K–N). This indicates that the and OXD-like enzymatic activity of Cu2MoS4 nanozymes increases with their concentration. Furthermore, the POD-like enzymatic activity of Cu2MoS4 nanozymes also increases with changes in the concentration of H2O2 (Fig. 1L–O), which is basically consistent with the changes in its OXD-like enzyme activity. With its outstanding enzyme-like activity, Cu2MoS4 nanozymes can produce ROS explosively within bacteria, achieving direct bactericidal effects; however, the intrinsic GSH in bacteria rapidly scavenges these ROS, weakening the antibacterial efficacy of the nanozyme. More critically, excessive GSH can also chelate free copper ions, further inhibiting the copper-induced bactericidal effect. Recent studies have indicated that various metal-based nanozymes possess glutathione peroxidase-like activity and can efficiently deplete intracellular GSH in bacteria [39]. To investigate whether Cu2MoS4 nanozymes have the ability to deplete GSH, DTNB probe was used as a specific fluorescent probe for detection. In the presence of glutathione peroxidase, DTNB is oxidized into the yellow DSNB. The results showed that over time, glutathione was gradually consumed and was completely depleted after 5 h of reaction (Fig. 1I). The above experimental results show that Cu2MoS4 nanozymes exhibit triple enzymatic activities of OXD-like, POD-like and GSH-px, enabling rapid accumulation of ROS, thereby enabling rapid ROS accumulation and synergistically achieving efficient bactericidal effects. The pH = 5.5 and substrate concentration chosen for the experiment are intended to simulate the weakly acidic microenvironment of a bacterial-infected wound. The substrate concentration is kept consistent with the material concentration used in the antibacterial experiment. By establishing this correlation, the catalytic activity results can more reasonably reflect the true enzyme-like performance of Cu2MoS4 nanozyme under conditions of antibacterial activity and wound healing. In addition, we used two different pH values to detect the Cu ion release ability of Cu2MoS4 nanozymes. Compared with pH = 7.4, Cu2MoS4 nanozymes showed the best Cu ion release ability at pH = 5.5, and also exhibited higher enzyme-like activity and better antibacterial performance under this pH condition (Figs. S2 and S3). Evaluation of the in vitro broad-spectrum antibacterial activities of Cu2MoS4 nanozymes Preliminary experiments have demonstrated that Cu2MoS4 nanozymes possess multiple enzymatic activities. Since burn wound infections often involve multiple bacterial species, to assess the actual bactericidal effect of Cu2MoS4 nanozymes, two representative gram-positive bacteria and 2 g-negative bacteria were selected for validation through plate assays and bacterial growth curves. In burn-infected wounds, the local inflammatory response and activated neutrophils produce a large amount of H2O2, which provides a natural microenvironment foundation for Cu2MoS4 nanozyme to exhibit enzyme-like catalytic activity. Cu2MoS4 can efficiently utilize the endogenously generated H2O2 at the wound site to achieve effective antibacterial action. Therefore, in order to simulate its real antibacterial microenvironment in the body, we conducted the following grouping. Each bacterial strain was divided into two groups: one treated with H2O2 and the other without, while six different concentrations of Cu2MoS4 nanozyme were used. The results indicated that Cu2MoS4 nanozymes exhibited concentration-dependent antibacterial effects against all four bacterial groups, and the antibacterial efficacy of the Cu2MoS4+H2O2 group was generally superior to that of the Cu2MoS4 group (Fig. 2A); this may be related to the POD-like enzyme activity of Cu2MoS4 nanozymes. In the Cu2MoS4+H2O2 group, even when the Cu2MoS4 concentration was 30 μg/ml, it exhibited a certain bactericidal effect against these four bacteria (Fig. 2B–E). The bacterial plating experiments preliminarily confirmed the bactericidal effect of Cu2MoS4 nanozymes, with the optimal antibacterial concentration being 150 μg/ml. To further investigate their ability to inhibit bacterial growth, the optimal concentration was used to establish four experimental groups: the control group (PBS), the H2O2 group, the Cu2MoS4 group, and the Cu2MoS4+ H2O2 group. Microplate reader was used to take measurements. The results indicated that in the Cu2MoS4 group, growth inflection points appeared approximately 4–6 h after material addition, whereas the Cu2MoS4+H2O2 group showed a trend of growth cessation (Fig. 2F–I). The antibacterial activity of Cu2MoS4 nanozymes was further evaluated using the live/dead bacterial staining dyes SYTO-9 and PI. Under a fluorescence microscope, the SYTO-9 probe can penetrate live bacteria and emit green fluorescence, whereas the PI probe can only penetrate dead bacteria and emit red fluorescence. The results demonstrated that the highest proportion of dead bacteria was identified in the Cu2MoS4+H2O2 group, followed sequentially by the Cu2MoS4 group, the H2O2 group, and the control group (PBS) (Fig. 2J–L). To determine the mode of interaction through which Cu2MoS4 nanozymes effectively kill bacteria, SEM was used to observe the morphology of bacterial colonies. The results showed that in the H2O2 group, most bacterial surfaces remained intact and showed no obvious rupture (Fig. 2J). However, in both the Cu2MoS4 and Cu2MoS4+H2O2 groups, Cu2MoS4 nanozymes were seen attached to the bacterial surfaces, causing varying degrees of surface indentation and damage, with the Cu2MoS4+H2O2 group showing the most extensive destruction (Fig. 2J). Based on the above experimental results, it was hypothesized that Cu2MoS4 nanozymes can utilize their enzyme-like activity to catalyze H2O2, thereby generating more ROS to effectively kill bacteria. DCFH-DA is intrinsically colorless, but ROS in bacterials can oxidize nonfluorescent DCFH to produce green DCF, which is observable under a fluorescence microscope. Therefore, DCFH-DA dye was used for ROS staining in each group. The results showed that Cu2MoS4 group showed weak green fluorescence (Fig. 2J), whereas the Cu2MoS4+ H2O2 group exhibited a striking increase in fluorescence intensity (Fig. 2M), indicating that Cu2MoS4 and H2O2 synergistically enhance ROS levels. The in vitro antibacterial activity of Cu2MoS4 nanozymes and its antibiofilm activity. (A) Plate results of Cu2MoS4 nanozymes on four bacteria with or without H2O2. (B–E) Statistics of the plating results of four types of bacteria. (F–I) Growth curves of four types of bacteria. (J–M) Fluorescence-stained images of live/dead MRSA and P.aeruginosa under different treatment conditions, SEM images, and fluorescence images of ROS along with the corresponding statistical charts. (N–R) Crystal violet staining of MRSA and P. aeruginosa biofilms after various treatments and SEM images of live/dead bacterial biofilms. The above experiments have preliminarily demonstrated that Cu2MoS4 nanozymes possess good broad-spectrum antibacterial activity in vitro. However, in actual burn wound infections, bacteria often exist in the form of biofilms. Bacterial biofilms can effectively protect bacteria from the killing effects of external antibiotics, leading to difficult-to-control infections. The ability to effectively remove biofilms would undoubtedly greatly control the extent and severity of burn wound infections. Crystal violet staining was used to preliminarily assess the biofilm inhibition or disruption ability of Cu2MoS4 nanozymes. Biofilms in the control and H2O2 groups remained intact and densely structured, whereas in the Cu2MoS4 group, the biofilms showed certain defects and fragmentation (Fig. 2N). More importantly, in the Cu2MoS4+H2O2 group, the biofilms formed by both bacterial strains nearly completely disappeared, demonstrating a good biofilm inhibition or disruption capability. Quantitative results also indicated a significant reduction of biofilms in the Cu2MoS4+H2O2 group (Fig. 2O–R). To more intuitively evaluate the biofilm inhibition or disruption effect of Cu2MoS4 nanozymes, SEM was employed to image biofilms in different treatment groups. Biofilms in the control and H2O2 groups retained a highly compact structure, while in the Cu2MoS4+H2O2 group, the biofilm structure was almost completely disintegrated, leaving only a few bacterial remnants (Fig. 2N). This result was highly consistent with the crystal violet staining results. These experimental results suggest that Cu2MoS4 nanozymes can generate ROS through their excellent enzyme-like activity, exhibiting strong broad-spectrum antibacterial activity and effective biofilm inhibition or disruption capability. Mechanisms of Cu2MoS4 nanozymes induced cuproptosis-like death in bacteria The antibacterial ability of Cu2MoS4 nanozyme has been verified. To further explore its antibacterial mechanism, P. aeruginosa, a clinically common strain, was selected for transcriptomic sequencing. The sequencing results indicated significant differential gene enrichment between the control group and the Cu2MoS4+H2O2 group (Fig. S4). The sequencing volcano plot revealed that the Cu2MoS4+H2O2 group had 309 downregulated genes and 188 upregulated genes (Fig. S5). GO functional enrichment analysis indicated a significant downregulation of differential genes in biological processes such as the TCA cycle, oxidative phosphorylation, iron-sulfur cluster binding, and the pentose phosphate pathway (Fig. 3A). Through further analysis of the sequencing results, genes differentially expressed between the control group (PBS) and the Cu2MoS4+H2O2 group samples were illustrated by generating a heatmap (Fig. 3B). The lpdG gene in P. aeruginosa encodes the E3 component of the α-ketoglutarate dehydrogenase complex [40]. It is a key subunit in both the TCA cycle and the mitochondrial electron transport chain, linking two major core pathways of energy metabolism. Relevant studies have confirmed that lpdG is associated with Cu + homeostasis, and its downregulation can facilitate abnormal accumulation of Cu+ [41]. The expression levels of lpdG and other genes encoding key enzymes in the TCA cycle were determined by qPCR. The results showed that lpdG, along with gltA, ancB, icd, sucC, and sucD, genes encoding key enzymes of the TCA cycle, were downregulated in both the Cu2MoS4 and Cu2MoS4+H2O2 treatment groups (Fig. 3F–L). Cu+ staining can demonstrate that a large amount of copper ions abnormally accumulated inside the bacterial cells (Fig. 4N–O). The impact on the TCA cycle and the accumulation of a large amount of copper ions inside the bacteria suggest that Cu2MoS4 nanozyme may trigger bacterial cuproptosis-like death. Relevant studies have confirmed that when copper ions accumulate inside bacteria, they can induce a process similar to copper-dependent cell death in eukaryotic cells, primarily manifested in their effects on oxidative phosphorylation and the TCA cycle. As the final reaction chain for ATP production, the respiratory chain plays a key role in bacterial ATP generation. Sequencing shows that Cu2MoS4 nanozymes significantly disrupt the respiratory chain's ability to synthesize ATP. Therefore, we examined the overall activity changes of respiratory chain complexes I and IV to investigate the effects of Cu2MoS4 nanozymes on the bacterial oxidative respiratory chain. The results showed that in both the Cu2MoS4 and Cu2MoS4 + H2O2 groups, the gene expressions encoding respiratory chain complexes I and IV were significantly downregulated, and the overall activities of them were also markedly decreased. Additionally, the gene expression encoding ATP synthase was significantly downregulated, severely impairing ATP synthesis, the primary energy source of bacteria. These findings corroborate the enrichment and heatmap results from gene sequencing, confirming that Cu2MoS4 nanozymes disrupt the function of the bacterial respiratory chain (Fig. 3M − O). In addition, as a key enzyme of the glyoxylate cycle, a critical branch of the TCA cycle, aceA was significantly downregulated, inhibiting the bacterial glyoxylate cycle and further disrupting bacterial energy metabolism. Furthermore, during cuproptosis-like death in bacteria, a large amount of lipid peroxides (LPOs) accumulates. To investigate the accumulation of LPOs, LPO fluorescence staining and malondialdehyde (MDA) assays were performed. The results indicated that LPO and MDA levels were significantly increased in both the Cu2MoS4 and Cu2MoS4+H2O2 groups, with the Cu2MoS4+H2O2 group showing higher levels than the Cu2MoS4-only group (Fig. 3C–E). These results indicate that the Cu2MoS4 nanozyme can cause bacterial metabolic disorder and lipid peroxidation damage by blocking the TCA cycle and the respiratory chain. Its mechanism of action is similar to cuproptosis in eukaryotes, thereby inducing cuproptosis-like death through a similar potential mechanism (Fig. 3P). Cu2MoS4 nanozymes trigger oxidative damage and cuproptosis-like death in P. aeruginosa. (A) GO enrichment chart. (B) Heatmap of genes enriched in cuproptosis-like death and oxidative damage. (C–D) Fluorescent staining images of lipid peroxides. (E) MDA assay. (F–L) Expression of key genes related to bacterial cuproptosis-like death and the TCA cycle. (M–O) Respiratory chain complex activity and ATPase gene expression in bacteria. (P) Schematic illustration of the mechanism underlying bacterial cuproptosis-like death and oxidative damage. Cu2MoS4 nanozymes weaken bacterial defenses through a dual mechanism. (A) Schematic diagram of Cu2MoS4 nanozymes inhibiting the ADI pathway. (B) KEGG enrichment map. (C) GO enrichment map. (D) GSEA enrichment map. (E) Schematic diagram of the mechanism by which molybdenum inhibits bacterial oxidative stress defense. (F) Heatmap of expression of key genes related to oxidative stress defense. (G–H) Expression levels of key oxidative stress defense genes in different treatment groups. (I-J, L-M) Expression levels of key ADI pathway genes. (K) Diagram of Cu2MoS4 nanozymes in vitro antibacterial mechanism. (N–O) Bacterial Cu+ fluorescence staining. Cu2MoS4 nanozymes downregulated bacterial defense through a dual mechanism P. aeruginosa enhances its survival and defense on the surface of infected wounds by forming a biofilm, while initiating the ADI metabolic pathway in the deeper layers of the biofilm to carry out anaerobic metabolism, producing a large amount of ATP to maintain its survival under harsh hypoxic conditions, greatly weakening the effectiveness of conventional antibacterial methods [[42], [43], [44]]. After treating the bacteria with Cu2MoS4 nanozymes, sequencing results indicated that the ADI pathway was significantly impaired, mainly affecting four key gene sets: arcA, arcB, arcC, and arcD (Fig. 4A–D). The expression of these four genes was further validated by qPCR, and the results revealed that in the Cu2MoS4+H2O2 group, the expression of all four gene sets were significantly downregulated (Fig. 4I–J, L-M). Inhibition of the ADI metabolic pathway hinders ATP production in deep biofilm bacteria, severely disrupting their energy metabolism, preventing them from maintaining normal physiological activities, and greatly reducing their ability to defend external stimuli [45,46]. Furthermore, through additional analysis of the sequencing results, it was found that molybdenum ions in Cu2MoS4 nanozymes could specifically downregulate the sodB and ahpC genes in P. aeruginosa, significantly impairing the bacterial defense against oxidative stress (Fig. 4F) [47]. Further validation was carried out using qPCR in six different experimental groups, and no significant downregulation of sodB or ahpC was observed in the Control, H2O2, or Cu2S groups. In contrast, downregulation was observed in the Na2MoO4 and Cu2MoS4 groups, with the most pronounced downregulation in the Cu2MoS4+H2O2 group (Fig. 4G–H). This confirms that the molybdenum component in Cu2MoS4 nanozymes can disrupt the bacteria's oxidative stress defense mechanisms, making it more difficult for bacteria to protect themselves against ROS-induced damage through their own antioxidant systems, greatly enhancing the bactericidal effect (Fig. 4E). Current research on molybdenum-based antibacterial agents mostly focuses on physicochemical pathways such as membrane damage, ROS generation, metal ion release, and photothermal effects [37]. The downregulation of sodB and ahpC genes by molybdenum explains the antibacterial mechanism from the perspective of transcriptional regulation of antioxidant genes, which may provide a theoretical basis for the development of new molybdenum-based antibacterial agents. These results suggest that Cu2MoS4 nanozymes inhibit the energy supply of bacteria in the deeper layers of biofilms by disrupting the ADI metabolic pathway and reducing ATP production from arginine fermentation, thereby impairing their ability to maintain normal physiological functions and defense mechanisms. Furthermore, the molybdenum in Cu2MoS4 nanozymes can specifically downregulate the sodB and ahpC genes, weakening the bacteria's oxidative stress defense system and making it more difficult for them to defend against ROS-induced cellular damage [48]. This dual mechanism not only reduces ATP production, disrupts the normal metabolism of bacterial cells, weakens their defense against copper ions, and makes them more vulnerable to ROS damage, but also allows copper ions to more easily enter the bacterial cells and accumulate in large amounts, greatly enhancing the bactericidal cuproptosis-like death. To further validate the levels of cuproptosis-like death in each group, we performed Cu + staining. The results indicated that copper accumulation could be triggered by the use of Cu2O alone, but with limited efficacy. A higher level of accumulation was observed in the Cu2MoS4 group compared to the Cu2O group, while the highest level of copper enrichment was achieved in the Cu2MoS4 + H2O2 group, demonstrating that the cuproptosis-like death can be amplified by Cu2MoS4 nanozymes (Fig. 4N–O). Therefore, the experimental findings above demonstrate that Cu2MoS4 nanozymes can effectively eliminate bacteria by inducing a bacterial cuproptosis-like death through interference with the lpdG gene. In addition, Cu2MoS4 nanozymes weaken bacterial defenses through a dual mechanism: 1. The arcA/arcB/arcC/arcD genes were downregulated, leading to inhibition of the ADI pathway in P. aeruginosa, which suppressed ATP production in biofilm bacteria and disrupted their normal defense mechanisms. 2. The molybdenum component downregulated the bacterial oxidative stress defense systems sodB and ahpC, thereby weakening resistance to ROS. This dual mechanism of bacterial defense downregulation further promoted intracellular copper ion accumulation, amplifying the bacterial cuproptosis-like death and substantially enhancing bactericidal efficiency (Fig. 4K). This copper/molybdenum dual-metal synergistic antibacterial mechanism may provide a new solution to the development of novel bactericides and the treatment of burn wound infections. Cu2MoS4 nanozymes accelerated the healing of burn-infected wounds in mice To further elucidate the therapeutic efficacy of Cu2MoS4 nanozymes on bacterial-infected wounds in vivo and their underlying mechanisms, a murine model of P. aeruginosa-infected burn wounds was established. This antimicrobial system takes the endogenous H2O2 in the microenvironment of burn infections as the core substrate for action, but its basal expression level is relatively insufficient. Based on the practical application background of clinical wound debridement, low-concentration exogenous H2O2 intervention was added in animal grouping, effectively enhancing the cascade catalytic effect of Cu2MoS4 nanozyme, improving the bactericidal effect, and simulating the high oxidative stress microenvironment of severely infected wounds. Mice were randomized into a control group, an H2O2 group, a Cu2MoS4 group, and a Cu2MoS4+H2O2 group. Deep second-degree burn wounds were generated on the dorsum of mice, which were then infected with P. aeruginosa to simulate P. aeruginosa-infected burn wounds (Fig. 5A). Next, we photographed the dorsal wounds of each group of mice. After 14 days, the healing of the dorsal wounds was comprehensively evaluated by comparing wound size, wound colony counts, as well as H&E and Masson staining. The wound healing speed in the Cu2MoS4 group and Cu2MoS4+H2O2 group was significantly accelerated, with a marked reduction in wound area after 14 days. Among them, the Cu2MoS4+H2O2 group exhibited the most pronounced healing effect, with wounds almost completely closed (Fig. 5B–E). Colony count results revealed the presence of numerous bacteria were still present on the wounds in the control and H2O2 groups, whereas the bacterial count in the Cu2MoS4+H2O2 group was markedly reduced (Fig. 5C–F). The histological characteristics of wound tissues across different mouse groups were further evaluated using H&E and Masson staining. Cu2MoS4 nanozymes accelerate wound healing in mice with burn infections. (A) Schematic diagram of the construction mechanism of burn wounds infected with P aeruginosa. (B) Wound photos and areas on days 4, 7, 10, and 14. (C) Bacterial plates and statistics of wounds in each group of mice. (D) H&E and Masson staining, CD31 immunohistochemistry, immunofluorescence staining of relevant inflammatory factors, and immunofluorescence staining of macrophage polarization in the dorsal wounds of mice on day 14. (E–F) Healing rate of dorsal wounds in mice, bacterial plate statistics, and statistical results of each staining. (G–K) Statistical results of relevant staining in mouse tissue sections. Note: 1. Control, 2. H2O2, 3. Cu2MoS4, and 4. Cu2MoS4+ H2O2. H&E staining indicated that in the Cu2MoS4+H2O2 group, inflammatory cell infiltration in the wound tissue was significantly reduced, granulation tissue proliferation was more mature, epidermal cell migration and proliferation were active. Conversely, the control and H2O2 groups still showed a large number of inflammatory cells, with no evident regeneration of skin appendages. Masson staining further revealed that the wound tissues in the Cu2MoS4+H2O2 group contained more orderly and dense collagen fibers, with a content significantly exceeded that of the other groups, indicating their effective promotion of wound tissue repair (Fig. 5D). Subsequently, angiogenesis in the wound tissues of each mouse group was further assessed by immunohistochemical staining for CD31. The results revealed that the Cu2MoS4+H2O2 group exhibited more CD31-positive areas, suggesting that Cu2MoS4+H2O2 can significantly promote neovascularization in the wounds (Fig. 5D–G). Inflammatory infiltration in tissues can impede the repair process; therefore, the wound tissues from each mouse group were evaluated by immunofluorescence staining for relevant inflammatory factors and macrophages. The results revealed that a large infiltration of inflammatory factors were observed in the control group and the H2O2 group, whereas the levels of inflammatory factors in the Cu2MoS4 group and the Cu2MoS4+H2O2 group were significantly reduced, with the Cu2MoS4+H2O2 group showing a more pronounced reduction (Fig. 5D–H-J). Simultaneously, immunofluorescence staining of macrophages showed that The M2/M1 macrophage ratio was significantly elevated in the Cu2MoS4+H2O2 group. This suggests that Cu2MoS4 nanozymes may alleviate wound inflammation by regulating macrophage phenotype conversion, thereby creating a favorable environment for tissue repair (Fig. 5D–K). To further explore the specific mechanism by which Cu2MoS4 nanozymes promote the healing of P. aeruginosa -infected burn wounds, high-throughput sequencing was performed using fresh wound tissues from the backs of mice. The heatmap of the sequencing results indicated a significant differential gene expression between the control group and the Cu2MoS4+H2O2 group (Fig. 6A). Subsequently, a volcano plot was generated, revealing that, compared with the control group, 160 genes were downregulated and 335 genes were upregulated in the Cu2MoS4+H2O2 group (Fig. 6B). GO enrichment analysis indicated that, the Cu2MoS4+H2O2 group primarily downregulated pathways related to leukocyte chemotaxis and neutrophil migration while upregulating pathways involved in epithelial cell development, differentiation, and keratinocyte maturation (Fig. 6C). Further KEGG enrichment analysis of the sequencing results demonstrated that, relative to the control group, pathways downregulated in the Cu2MoS4+H2O2 group mainly involved inflammatory signaling pathways such as TNF and NF-kappa B, effectively alleviating tissue inflammation (Fig. 6D). GSEA analysis results indicated that pathways related to angiogenesis and cell proliferation were significantly upregulated, whereas associated inflammatory pathways were significantly downregulated (Fig. 6E). However, the weights of the mice did not change significantly (Fig. S6). Therefore, Cu2MoS4 nanozymes promote the healing of burn-infected wounds not only by relying on its antibacterial effect, but also by effectively regulating macrophage phenotypes through inhibiting the activation of inflammation-related pathways, while simultaneously promoting the upregulation of angiogenesis and cell proliferation-related pathways, thereby effectively alleviating the inflammatory response of burn wounds and synergistically achieving efficient wound tissue repair with the antibacterial effect (Fig. 6F) [49]. Sequencing results of burn-infected wounds on mouse backs. (A) Heatmap of significantly expressed genes following P. aeruginosa infection. (B) Volcano plot of genes after P.aeruginosa infection. (C) GO enrichment analysis. (D) KEGG enrichment analysis. (E) GSEA showing significant differences after Cu2MoS4+ H2O2 treatment. (F) Mechanism of Cu2MoS4 nanozymes in accelerating the healing of burn-infected wounds. Cu2MoS4 nanozymes accelerated the healing of infected burn wounds in New Zealand rabbits Preliminary experimental results have demonstrated that Cu2MoS4 nanozymes exhibit a favorable therapeutic effect on burn-infected wounds in mice. Nevertheless, due to structural differences between murine and human epidermis, further investigation of Cu2MoS4 nanozymes remained limited. Therefore, the New Zealand rabbit was chosen as the experimental subject because its skin structure is more similar to that of humans. This model better simulates the healing process of deep Ⅱ-degree burn infections in humans. Accordingly, deep Ⅱ-degree infected burn wounds were established on the backs of New Zealand rabbits to further validate the in vivo antibacterial efficacy of Cu2MoS4 nanozymes and their ability to promote wound healing (Fig. 7A). The results indicate that after 14 days, the Cu2MoS4+H2O2 group exhibited almost complete healing of dorsal wounds, demonstrating the best therapeutic effect (Fig. 7B–C). Further, bacterial smear tests were employed to assess bacterial infection on the dorsal wounds of New Zealand rabbits in each group. The Cu2MoS4+H2O2 group showed almost no bacterial growth (Fig. 7D–E). To further assess dorsal wound healing of New Zealand rabbits, H&E and Masson staining were performed. In the control group, H&E staining revealed marked inflammatory cell infiltration, while the Cu2MoS4+H2O2 group exhibited markedly reduced inflammatory cell infiltration, indicating a significant reduction in wound inflammation. Additionally, Masson staining showed collagen fibers in the control group were disordered and sparse, whereas those in the Cu2MoS4+H2O2 group were more regularly arranged and dense, suggesting that Cu2MoS4+H2O2 treatment promotes normal collagen deposition (Fig. 7F–I). Therefore, through in vivo antibacterial experiments on mice and New Zealand rabbits, Cu2MoS4 nanozymes can accelerate the healing of burn-infected wounds in vivo by mechanisms including modulation of local wound inflammation, promotion of angiogenesis, and facilitation of epithelial cell development and differentiation. Cu2MoS4 nanozymes accelerate wound healing in burn-infected New Zealand rabbits. (A) Schematic illustration of the procedure for establishing P. aeruginosa-infected burn-infected wounds. (B) Wound photographs and area measurements at various time points. (C) Rabbit wound healing rates at various time points. (D–E) Statistics of bacterial coating and wound exudate. (F) H&E and Masson staining on day 14. (G–I) Statistics of epidermal thickness, number of skin appendages, and collagen deposition rate in each group. Biocompatibility assessment of Cu2MoS4 nanozymes The biosafety of inorganic nanomaterials constitutes a crucial aspect that requires rigorous evaluation. Accordingly, a CCK-8 assay was performed using mouse fibroblast cells (L929) to assess their biocompatibility. Results indicated that even at a Cu2MoS4 concentration of 200 μg/mL, no significant decrease in cell viability was observed (Fig. S9). Hemolysis test results indicated that Cu2MoS4 nanozymes exhibit excellent blood compatibility (Fig. S8). Therefore, according to the results of our in vitro antibacterial experiments, the experimental concentration of 150 μg/ml remains within a safe range. Furthermore, at day 14 post-treatment, major organs were harvested from all mice and subjected to H&E staining, and the results revealed no obvious abnormal change (Fig. S7). Also, the blood routine and biochemical indicators of all groups of mice were within normal range (Fig. S10). Thus, Cu2MoS4 nanozymes are highly biocompatible at the experimental concentration. Conclusion In this study, hollow-structured copper-molybdenum bimetallic Cu2MoS4 nanozymes were successfully synthesized using a simple hydrothermal method. Endowed with multi-enzymatic activities, Cu2MoS4 nanozymes can generate abundant ROS while depleting endogenous GSH in bacteria, thereby exerting excellent antibacterial effects and efficiently disrupting biofilms in vitro. The expression of the lpdG gene was specifically downregulated by Cu2MoS4 nanozymes, leading to increased accumulation of Cu+ and subsequently inducing cuproptosis-like death in the bacteria. The ADI metabolic pathway in bacteria was interfered with by Cu2MoS4 nanozymes, resulting in the inhibition of ATP production in the deep layers of biofilm and the consequent disruption of their normal metabolism and defense mechanisms. Additionally, sodB and ahpC were specifically downregulated by the molybdenum component, which weakened the bacterial oxidative stress defense system and increased bacterial susceptibility to ROS attack. The downregulation of bacterial defenses led to further accumulation of copper ions inside the cells, synergistically amplifying the cuproptosis-like death and greatly enhancing bactericidal capability. In vivo experiments revealed that Cu2MoS4 nanozymes accelerated the healing of burn-infected wounds on the backs of mice and New Zealand rabbits by reducing tissue inflammation, regulating macrophage polarization, and promoting vascular regeneration as well as epithelial cell regeneration and differentiation, while exhibiting good biocompatibility. It is worth noting that, compared with the previously reported copper-based and molybdenum-based nanomaterials [38], the latter achieve antibacterial effects through ultrasonic or photothermal activation, Cu2MoS4 nanozymes can release copper ions and downregulate bacterial defense pathways in acidic infection microenvironments without external stimulation, inducing and amplifying cuproptosis-like death [50]. This leads to more thorough antibacterial activity and lower likelihood of resistance. They are suitable for various infected wounds and also possess anti-inflammatory and tissue repair-promoting functions, making them more suitable for clinical infection treatment [51]. Therefore, Cu2MoS4 nanozymes effectively eradicate bacteria through multiple mechanisms, including the reduction of bacterial defenses and amplification of cuproptosis-like death, which collectively contribute to significantly accelerated healing of infected burn wounds. This offers a potential therapeutic strategy for post-burn bacterial infections. Methods Synthesis of Cu2MoS4 nanozymes First, 80 mg of Cu2O and 240 mg of glucose were dissolved in 40 mL ethylene glycol, and then subject the solution to ultrasonic treatment to ensure thorough dispersion. Then, 70 mg of Na2MoO4·2H2O and 120 mg of C2H5NS were sequentially added to the solution, and continue ultrasonic treatment of the mixed solution for 30 min. Next, transfer the mixed solution into a stainless-steel high-pressure reactor and react for 24 h at 200 °C. Then wash the obtained product three times and finally dry it in a vacuum oven at 60 °C to obtain Cu2MoS4 nanozymes. Characterization of Cu2MoS4 nanozymes The morphology and structure of the nanozyme were observed using TEM (Hitachi H7700) and HRTEM. The valence states and related components of various elements in Cu2MoS4 nanozymes were determined using X-ray diffraction (XRD, Bruker D8 Advanced) and X-ray photoelectron spectroscopy (XPS, Thermo Fisher, USA). The distribution of relevant elements in Cu2MoS4 nanozymes was analyzed using energy-dispersive spectroscopy (EDS). Enzymatic activities assay of Cu2MoS4 nanozymes The Cu2MoS4 nanozymes prepared in this study exhibited multiple enzymatic activities. Firstly, the POD-like and OXD-like activities of the Cu2MoS4 nanozymes were evaluated using TMB and OPD probes, respectively. Experiments were conducted with varying concentrations of hydrogen peroxide and different concentrations of Cu2MoS4 nanozymes, while maintaining the pH at 5.5 across all experimental groups. After reacting for 10 min, absorbance values at 652 nm and 435 nm were measured using a microplate reader to assess the POD-like and OXD-like activities. Furthermore, using GSH as the substrate, the DTNB colorimetric method was applied to measure absorbance at 412 nm to evaluate the GSH-oxidase activity of Cu2MoS4 nanozymes. In vitro antibacterial activity of Cu2MoS4 nanozymes Bacterial plate coating experiment: Methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Escherichia coli and P. aeruginosa were selected for in vitro plate coating assays. All procedures were performed under strict aseptic conditions to prevent bacterial contamination. First, frozen glycerol stocks of the strains were inoculated into liquid medium and incubated overnight. A concentration gradient of Cu2MoS4 nanozymes (0, 30, 60, 90, 120, 150 μg/mL) were prepared and divided into two sets: with 100 μM H2O2 and without H2O2. Each treatment group were serially diluted, spread evenly on agar plates (triplicate per condition), and incubated overnight. Colonies were counted using ImageJ software, and the relative survival rate was calculated. Bacterial growth curve experiment: This experiment included four groups (Control, H2O2, Cu2MoS4, Cu2MoS4+H2O2). The Cu2MoS4 group was set at a concentration of 150 μg/mL, and the H2O2 group at 100 μM. The initial OD600 of the bacteria in all four groups was set to 0.1. The bacteria in these four treatment groups were continuously monitored at 37 °C for 18 h. At 2-h intervals, the absorbance at 600 nm was measured using a microplate reader (SpectraMax iD3). The bacterial growth curves were plotted using Origin software (n = 3). Bacterial live/dead staining: Four experimental groups (Control, H2O2, Cu2MoS4, and Cu2MoS4+H2O2) were established, with the concentration of Cu2MoS4 nanozymes fixed at 150 μg/mL. Two bacterial species, Escherichia coli and P. aeruginosa were cultured and the samples were stained with SYTO 9 and PI and incubated at 37 °C. Observations and imaging were performed using a confocal laser scanning microscope (CLSM), and the resulting data were analyzed with ImageJ software. Bacterial ROS staining: Four experimental groups (Control, H2O2, Cu2MoS4, and Cu2MoS4+ H2O2) were established using a Cu2MoS4 nanozymes concentration of 150 μg/mL. Two bacterial species, Escherichia coli and P. aeruginosa, were grown to an OD600 of 0.6 for the assay. Following 4 h of co-culture, DCFH-DA was added as the ROS-sensitive fluorescent probe. Samples were then observed and imaged with CLSM, and the acquired data were processed using ImageJ software. Inhibition of bacterial biofilms: Four experimental groups (Control, H2O2, Cu2MoS4, and Cu2MoS4+ H2O2) were established with a fixed Cu2MoS4 nanozymes concentration of 150 μg/mL. Two representative bacterial species, Escherichia coli and P. aeruginosa, were grown to an OD600 of 0.6. Biofilms were formed by co-culturing each group at 37 °C. The resulting biofilms were then quantitatively assessed by crystal violet staining and morphologically characterized by SEM (n = 3). Bacterial biofilm disruption: First, MRSA and P. aeruginosa bacterial suspensions (OD600 = 0.6) were cultured in 24-well plates at 37 °C. After confirming biofilm formation, the cultures were divided into four groups (Control, H2O2, Cu2MoS4, Cu2MoS4+H2O2). Cu2MoS4 nanozymes were used at a concentration of 150 μg/mL, and hydrogen peroxide at 100 mM. Each group was treated with the corresponding components and incubated at 37 °C. Subsequently, biofilm formation in each group was assessed via crystal violet staining and SEM (n = 3). Cu + fluorescence staining Five groups were established (Control, H2O2, Cu2O, Cu2MoS4, Cu2MoS4+H2O2), with the Cu2MoS4 nanozymes at a concentration of 150 μg/mL. Cu2O was tested using P. aeruginosa (OD600 = 0.6), with its molar concentration equivalent to that of Cu2MoS4 nanozymes. After co-incubation for 4 h, Coppersensor 1 dye was added and incubated for 5 min. Fluorescence confocal microscopy was then used to observe and photograph the staining results of each group, and the images were processed and analyzed using ImageJ (n = 3). Biosafety assessment To evaluate the biocompatibility of Cu2MoS4 nanozymes, biosafety was assessed through CCK-8 cytotoxicity assays and hemolysis tests. Further in vivo biosafety evaluations were performed by examining histological sections of the heart, liver, spleen, lungs, and kidneys, along with hematological parameters in experimental animals. Statistical analysis All data are shown as mean ± SD from three independent experiments. Differences between two groups were analyzed by Student's t-test. For normally distributed data involving comparisons among multiple groups, one-way analysis of variance was applied. Statistical significance levels are denoted as ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Ethics approval and consent to participate All animal experiments were approved by the Ethics Committee of Anhui Medical University (No. LLSC20261942). CRediT authorship contribution statement Yunfeng Zheng: Data curation, Validation, Visualization, Writing – original draft. Shuo Zhang: Data curation, Validation, Visualization, Writing – original draft. Xu-Lin Chen: Funding acquisition, Resources, Supervision, Writing – review & editing. Xianwen Wang: Funding acquisition, Methodology, Supervision, Writing – review & editing. Declaration of competing interest The authors declare that they have no competing financial interests. Acknowledgments This work was supported by the National Natural Science Foundation of China (82172204, 82372552, 82372517), the Anhui Key Research and Development Plan (202104j07020027), the Excellent Youth of Natural Science Research Projects in Anhui Province Universities (2023AH030060), the Anhui Provincial Natural Science Foundation (2408085Y016), the Anhui Province Excellent Research and Innovation Team Project (2024AH010013), andthe Anhui Clinical Medical Research Transformation Project(202427b10020143). The authors would like to thank the Shiyan laboratory (www.shiyanjia.com) for their help in language polishing. Figures were created by Biorender (https://www.biorender.com). Footnotes Peer review under the responsibility of editorial board of Bioactive Materials. Supplementary data to this article can be found online at https://doi.org/10.1016/j.bioactmat.2026.05.056. Contributor Information Xu-Lin Chen, Email: xianwenwang@ahmu.edu.cn. Xianwen Wang, Email: chenxulin@ahmu.edu.cn. Supplementary data The following is the Supplementary data to this article: Multimedia component 1 References Associated Data Supplementary Materials Multimedia component 1